Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
44
HYPMY Quote, Financials, Valuation and Earnings
Last price:
$4.50
Seasonality move
:
2.98%
Day range:
$4.69 - $4.96
52-week range:
$2.64 - $5.18
Dividend yield:
1.17%
P/E ratio:
20.10x
P/S ratio:
2.43x
P/B ratio:
1.29x
Volume:
22.2K
Avg. volume:
8.5K
1-year change:
50.93%
Market cap:
$3B
Revenue:
$1.4B
EPS (TTM):
$0.23
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Hypera SA has -- downside to fair value with a price target of -- per share.
HYPMY vs. S&P 500
-
Over the past 5 trading days, Hypera SA has underperformed the S&P 500 by -4.87% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Hypera SA does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Hypera SA has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Hypera SA reported revenues of $408.8M.
Earnings Growth
-
Hypera SA has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Hypera SA reported earnings per share of $0.13.
Enterprise value:
4.4B
EV / Invested capital:
1.08x
Price / LTM sales:
2.43x
EV / EBIT:
21.06x
EV / Revenue:
3.55x
PEG ratio (5yr expected):
16.41x
EV / Free cash flow:
40.56x
Price / Operating cash flow:
27.77x
Enterprise value / EBITDA:
16.68x
Gross Profit (TTM):
$666.6M
Return On Assets:
2.97%
Net Income Margin (TTM):
12.04%
Return On Equity:
6.9%
Return On Invested Capital:
3.84%
Operating Margin:
30.11%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.6B | $1.5B | $1.2B | $345.5M | $408.8M | |
| Gross Profit | $996M | $886.6M | $666.6M | $198.8M | $240.9M | |
| Operating Income | $523M | $424.4M | $207.5M | $80.5M | $123.1M | |
| EBITDA | $565.9M | $476.3M | $262M | $93.1M | $137.6M | |
| Diluted EPS | $0.55 | $0.48 | $0.23 | $0.11 | $0.13 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.3B | $1.4B | $1.6B | $1.6B | $1.2B | |
| Total Assets | $4B | $4.6B | $5.4B | $5.3B | $5.4B | |
| Current Liabilities | $631.1M | $765.3M | $856.2M | $890.1M | $931.5M | |
| Total Liabilities | $2.3B | $2.6B | $3.1B | $3.1B | $3.1B | |
| Total Equity | $1.8B | $1.9B | $2.3B | $2.2B | $2.3B | |
| Total Debt | $1.2B | $1.4B | $1.6B | $1.6B | $1.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $182.7M | $275.7M | $264.9M | $104.1M | $123.5M | |
| Cash From Investing | -$166.4M | -$105.8M | -$135.7M | -$24.4M | -$23.4M | |
| Cash From Financing | -$19.9M | $22.7M | -$385.1M | -$10.7M | $15M | |
| Free Cash Flow | $11.7M | $136.5M | $107.8M | $71M | $92.2M | |
HYPMY
Sector
Market Cap
$3B
$28.5M
Price % of 52-Week High
90.54%
51.44%
Dividend Yield
1.17%
0%
Shareholder Yield
5.87%
-1.33%
1-Year Price Total Return
43.21%
-20.32%
Beta (5-Year)
0.736
0.520
Dividend yield:
1.17%
Annualized payout:
$0.17
Payout ratio:
26.97%
Growth streak:
1 years
Technicals
8-day SMA
Sell
Level
$4.89
200-day SMA
Buy
Level
$4.23
Bollinger Bands (100)
Buy
Level
4.11 - 4.77
Chaikin Money Flow
Buy
Level
6.3M
20-day SMA
Sell
Level
$4.84
Relative Strength Index (RSI14)
Sell
Level
48.74
ADX Line
Buy
Level
20.55
Williams %R
Buy
Level
-84.4828
50-day SMA
Buy
Level
$4.46
MACD (12, 26)
Buy
Level
0.10
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Sell
Level
-21.4M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.1531)
Sell
CA Score
(Annual)
Level (-0.4069)
Buy
Beneish M-Score
(Annual)
Level (-2.757)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (0.231)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Hypera SA is a pharmaceutical company, which engages in the manufacture and distribution of medical and cosmetics products. It operates through the following segments: Prescription Products, Consumer Health, Similar and Generic Drugs, Skincare, and Institutional Market. The company was founded by João Alves de Queiroz Filho on December 1, 2001 and is headquartered in Sao Paulo, Brazil.
Stock Forecast FAQ
In the current month, HYPMY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HYPMY average analyst price target in the past 3 months is --.
-
Where Will Hypera SA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Hypera SA share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Hypera SA?
Analysts are divided on their view about Hypera SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Hypera SA is a Sell and believe this share price will rise from its current level to --.
-
What Is Hypera SA's Price Target?
The price target for Hypera SA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HYPMY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Hypera SA is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of HYPMY?
You can purchase shares of Hypera SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Hypera SA shares.
-
What Is The Hypera SA Share Price Today?
Hypera SA was last trading at $4.50 per share. This represents the most recent stock quote for Hypera SA. Yesterday, Hypera SA closed at $4.69 per share.
-
How To Buy Hypera SA Stock Online?
In order to purchase Hypera SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get HYPMY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HYPMY
Sector
P/E ratio
20.10x
23.75x
PEG ratio
16.41x
-0.01x
P/B ratio
1.29x
1.83x
Price / LTM sales
2.43x
1.60x
Growth Metrics
HYPMY
Sector
Revenue growth
18.32%
4.85%
Earnings growth
23.71%
11.11%
Revenue (5-year growth)
10.57%
6.45%
Earnings forecast
--
-$0.20
Profitability
HYPMY
Sector
Profitability FY 2024
$780.3M
$3.6M
Return on invested capital
3.84%
-30.98%
Return on assets
2.97%
-27.62%
Return on equity
6.9%
-36.69%
Earnings Date
Last Earnings Date
Oct
28
Next Earnings Date
Mar
11
Estimated Next Earnings Date
Jan
27
Balance Sheet
HYPMY
Sector
Total cash
$350M
$27.2M
Short term investments
--
$25.7M
Total assets
$4.5B
$79.7M
Long term debt
$1.4B
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 9.18% over the past day.
Sell
13
PSN alert for Dec 8
Parsons Corp. [PSN] is down 5.19% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
